Document is current
Any future updates will be listed below
-
Authors
Størset, Elisabet
Bråten, Line Skute
Ingelman-Sundberg, Magnus
Johansson, Inger
Molden, Espen
Kringen, Marianne Kristiansen
-
Funding
Funding for this research was provided by:
The Swedish Research Council (2021-02801, 2021-02801)
Diakonhjemmet Hospital
- License Information
-
More Information
Article History
Received: 22 March 2024
Accepted: 23 June 2024
First Online: 4 July 2024
Change Date: 19 July 2024
Change Type: Update
Change Details: Electronic Supplementary Material caption minor update.
Declarations
:
: The study was approved by the Regional Committee for Medical and Health Research Ethics (#2020/127234), and the Hospital Investigational Review Board approved the study. The included subjects had been given written information about the study with the possibility to reserve from study participation.
: Magnus Ingelman-Sundberg is co-founder and co-owner of HepaPredict AB. The remaining authors have no competing interests to declare that are relevant to the content of this article.
